Medical Devices

Implantable devices need to undergo rigorous biocompatibility assessments before they can be tested in clinical trials. We can save you money by identifying lead candidate biomaterials prior to in vivo testing.

  • FDA-required biocompatibility assessments include extensive in vivo testing, which can be both expensive and ethically questionable. Additionally, in vitro and cell culture assays may not be adequately predictive of the in vivo response to biomaterials and devices. Our ex vivo models allow you to bridge the gap between in vitro and in vivo testing by determining human and/or porcine tissue responsiveness to your product.
  • Our models are predictive of the in vivo response, allowing you to identify lead candidates and drop cytotoxic/ineffective formulations before they are tested in animals. This will decrease the number of animals needed for in vivo testing and accelerate your project’s transition to the clinical stage.

Models Used

Biofilm Reactor

Learn how we use our biofilm reactors to evaluate biofilm formation on a large variety of materials.

Our reactors serve as a testing platform for drugs or devices against biofilms grown on abiotic surfaces. We can determine whether bacteria will grow to a biofilm in the presence of your materials.

Our reactors are an excellent testing platform for materials in development. They allow us to determine how bacteria will adhere, form biofilm, and grow in the presence of your developmental materials.

Learn more

Porcine Mucosal Model (PMM)

Find out how our porcine mucosal model facilitates high-volume testing and provides highly reproducible results.

We apply this model to compounds requiring infectious disease testing. The mucosal tissue serves as an optimal environment for the growing of pathogens. We test against either planktonic or biofilm infections in this model.

This model serves as a unique means of testing for inflammatory cytokines in a cost-effective manner. We can perform ELISAs to determine whether experimental compounds are pro- or anti-inflammatory.

Much of the human genital tract is composed of mucosal tissue. Therefore, this model is excellent for predictive preclinical testing of compounds or products relating to urogenital health.

Using our mucosal model, we can measure bacterial adhesion and host cell toxicity to experimental devices.

Learn more